Chronic Apical Periodontitis

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Using advanced platelet-rich fibrinN/A1 trial
Active Trials
NCT07192289Not Yet RecruitingEst. Aug 2027

Trial Timeline

Clinical trial activity over time

2025
2026
2027
City TherapeuticsUsing advanced platelet-rich fibrin

Clinical Trials (1)

NCT07192289City TherapeuticsUsing advanced platelet-rich fibrin

Using Platelet-rich Fibrin in Regenerative Endodontic Treatment in Mature Permanent Teeth

Start: Sep 2025Est. completion: Aug 2027
N/ANot Yet Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space